OFLORAX-M Suspension is given to children for the treatment of bacterial infections of the teeth, lungs, gastrointestinal tract, urinary tract, and genital tract. This medicine is also given as an empirical antibiotic for infected diarrhea mixed with blood and serious infections like peritonitis.
Give OFLORAX-M Suspension to your child orally, preferably at a fixed time, either before or after meals. In case your child develops a stomach upset, prefer giving it with meals. Generally, this medicine is prescribed to be given two times a day, in the morning and evening. If your child vomits within 30 minutes of intake, repeat the same dose but do not double the dose if it is time for the next dose. Never change the dose, time, and way prescribed by the doctor since these depend upon the type and severity of the infection, your child's age, and body weight.
Find products similar to Ofloxacin Metronidazole Simethicone, 60 Ml
Interested in this product?Get Latest Price from the seller
About the Company
GST Registration Date
29-09-2021
Legal Status of Firm
Proprietorship
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
5 - 25 Cr
IndiaMART Member Since
Dec 2021
GST
06BEZPG8865D1ZW
We are creating a strong and vibrant brand that offers quality pharmaceuticals at economical prices. Our chemical hubs and manufacturing plants have a huge capacity to formulate broad product range that covers up all major therapeutic areas and health problems. At the same time, we strive hard to ensure prompt delivery, leakage & breakage prove the packaging of all our formulated medicines range.
We also welcome skilled Pharma professionals who are keen to make their bright career as a businessman in Pharma industry, as we offer them best Pharma franchise opportunities to let them grow by setting up a Pharma franchise business in their own locality on a monopoly basis. We provide all kinds of supports gradually so that they could not find any issue while running this Pharma franchise business.
